Browse > Article
http://dx.doi.org/10.1016/j.jgr.2015.07.002

Role of microRNA-520h in 20(R)-ginsenoside-Rg3-mediated angiosuppression  

Keung, Man-Hong (Department of Biology, Faculty of Science, Hong Kong Baptist University)
Chan, Lai-Sheung (Department of Biology, Faculty of Science, Hong Kong Baptist University)
Kwok, Hoi-Hin (Department of Biology, Faculty of Science, Hong Kong Baptist University)
Wong, Ricky Ngok-Shun (Department of Biology, Faculty of Science, Hong Kong Baptist University)
Yue, Patrick Ying-Kit (Department of Biology, Faculty of Science, Hong Kong Baptist University)
Publication Information
Journal of Ginseng Research / v.40, no.2, 2016 , pp. 151-159 More about this Journal
Abstract
Background: Ginsenoside-Rg3, the pharmacologically active component of red ginseng, has been found to inhibit tumor growth, invasion, metastasis, and angiogenesis in various cancer models. Previously, we found that 20(R)-ginsenoside-Rg3 (Rg3) could inhibit angiogenesis. Since microRNAs (miRNAs) have been shown to affect many biological processes, they might play an important role in ginsenoside-mediated angiomodulation. Methods: In this study, we examined the underlying mechanisms of Rg3-induced angiosuppression through modulating the miRNA expression. In the miRNA-expression profiling analysis, six miRNAs and three miRNAs were found to be up- or down-regulated in vascular-endothelial-growth-factor-induced human-umbilical-vein endothelial cells (HUVECs) after Rg3 treatment, respectively. Results: A computational prediction suggested that mature hsa-miR-520h (miR-520h) targets ephrin receptor (Eph) B2 and EphB4, and hence, affecting angiogenesis. The up-regulation of miR-520h after Rg3 treatment was validated by quantitative real-time polymerase chain reaction, while the protein expressions of EphB2 and EphB4 were found to decrease, respectively. The mimics and inhibitors of miR- 520h were transfected into HUVECs and injected into zebra-fish embryos. The results showed that overexpression of miR-520h could significantly suppress the EphB2 and EphB4 protein expression, proliferation, and tubulogenesis of HUVECs, and the subintestinal-vessel formation of the zebra fish. Conclusion: These results might provide further information on the mechanism of Rg3-induced angiosuppression and the involvement of miRNAs in angiogenesis.
Keywords
anti-angiogenesis; ginsenoside-Rg3; microRNA; miR-520h;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kim VN, Nam JW. Genomics of microRNA. Trends Genet 2006;22:165-73.   DOI
2 Ambros V. The functions of animal microRNAs. Nature 2004;431:350-5.   DOI
3 Erson AE, Petty EM. MicroRNAs in development and disease. Clin Genet 2008;74:296-306.   DOI
4 Chan LS, Yue PY, Mak NK, Wong RN. Role of microRNA-214 in ginsenoside- Rg1-induced angiogenesis. Eur J Pharm Sci 2009;38:370-7.   DOI
5 Chan LS, Yue PY, Wong YY, Wong RN. MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2. Biochem Pharmacol 2013;86:392-400.   DOI
6 Chan YK, Kwok HH, Chan LS, Leung KS, Shi J, Mak NK, Wong RN, Yue PY. An indirubin derivative, E804, exhibits potent angiosuppressive activity. Biochem Pharmacol 2012;83:598-607.   DOI
7 Nagpal M, Nagpal K, Nagpal PN. A comparative debate on the various antivascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin). Indian J Ophthalmol 2007;55:437-9.   DOI
8 Scapoli L, Palmieri A, Lo Muzio L, Pezzetti F, Rubini C, Girardi A, Farinella F, Mazzotta M, Carinci F. MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol 2010;23:1229-34.   DOI
9 Hromadnikova I, Kotlabova K, Jirasek JE, Doucha J. Detection of lacentaspecific microRNAs in maternal circulation. Ceska Gynekol 2010;75:252-6 [Czech].
10 Su JL, Chen PB, Chen YH, Chen SC, Chang YW, Jan YH, Cheng X, Hsiao M, Hung MC. Downregulation of microRNA miR-520h by E1A contributes to anticancer activity. Cancer Res 2010;70:5096-108.   DOI
11 Yu YH, Chen HA, Chen PS, Cheng YJ, Hsu WH, Chang YW, Chen YH, Jan Y, Hsiao M, Chang TY, et al. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene 2013;32:431-43.   DOI
12 Wang F, Xue X, Wei J, An Y, Yao J, Cai H, Wu J, Dai C, Qian Z, Xu Z, et al. hsamiR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br J Cancer 2010;103:567-74.   DOI
13 Cheng N, Brantley DM, Chen J. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 2002;13:75-85.   DOI
14 Zhang J, Hughes S. Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J Pathol 2006;208:453-61.   DOI
15 Salvucci O, Tosato G. Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Adv Cancer Res 2012;114:21-57.
16 Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 1999;13:295-306.   DOI
17 Steinle JJ, Meininger CJ, Forough R, Wu G, Wu MH, Granger HJ. Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J Biol Chem 2002;277:43830-5.   DOI
18 Heroult M, Schaffner F, Augustin HG. Eph receptor and ephrin ligandmediated interactions during angiogenesis and tumor progression. Exp Cell Res 2006;312:642-50.   DOI
19 Kuijper S, Turner CJ, Adams RH. Regulation of angiogenesis by Epheephrin interactions. Trends Cardiovasc Med 2007;17:145-51.   DOI
20 Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu ME, Acker T, Acker-Palmer A. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 2010;465:487-91.   DOI
21 Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Luthi U, et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 2010;465:483-6.   DOI
22 Horowitz A, Seerapu HR. Regulation of VEGF signaling by membrane traffic. Cell Signal 2012;24:1810-20.   DOI
23 Yue PY, Wong DY, Ha WY, Fung MC, Mak NK, Yeung HW, Leung HW, Chan K, Liu L, Fan TP, et al. Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg(1) in vivo and in vitro. Angiogenesis 2005;8:205-16.   DOI
24 Chan LS, Yue P, Kok TW, Keung MH, Mak NK, Wong R. Ginsenoside-Rb1 promotes adipogenesis through regulation of $PPAR{\gamma}$ and microRNA-27b. Horm Metab Res 2012;44:819-24.   DOI
25 Kwok HH, Yue PYK, Mak NK, Wong RNS. Ginsenoside Rb1 induces type I collagen expression through peroxisome proliferator-activated receptordelta. Biochem Pharmacol 2012;84:532-9.   DOI
26 Kwok HH, Guo GL, Lau JKC, Cheng YK, Wang JR, Jiang ZH, Keung MH, Mak NK, Yue PY, Wong RN. Stereoisomers ginsenosides-20(S)-$Rg_3$ and -20(R)-Rg3 differentially induce angiogenesis through peroxisome proliferator-activated receptor-gamma. Biochem Pharmacol 2012;83:893-902.   DOI
27 Liu TG, Huang Y, Cui DD, Huang XB, Mao SH, Ji LL, Song HB, Yi C. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer 2009;9:1471-2407.
28 Chen J, Peng H, Ou-Yang X, He X. Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells. Melanoma Res 2008;18:322-9.   DOI
29 Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, Tono-oka S, Samukawa K, Azuma I. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull 1995;18:1197-202.   DOI
30 Yue PY, Wong DY, Wu PK, Leung PY, Mak NK, Yeung HW, Liu L, Cai Z, Jiang ZH, Fan TP, et al. The angiosuppressive effects of 20(R)-ginsenoside Rg3. Biochem Pharmacol 2006;72:437-45.   DOI
31 Zhang Q, Kang X, Yang B, Wang J, Yang F. Antiangiogenic effect of capecitabine combined with ginsenoside Rg3 on breast cancer in mice. Cancer Biother Radiopharm 2008;23:647-53.   DOI
32 Xu TM, Xin Y, Cui MH, Jiang X, Gu LP. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chin Med J (Engl) 2007;120:584-8.
33 Huang X, Hou M, Yi C, Song H. Anti-angiogenic effects of low-dose gemcitabine combined with ginsenoside Rg3 on mouse Lewis lung carcinoma. Zhongguo Fei Ai Za Zhi 2006;9:132-6 [Chinese].
34 Kang XM, Zhang QY, Tong DD, Zhao W. Experimental study on antiangiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005;25:730-3 [Chinese].
35 Chen MW, Ma AQ, Ni L, Huang C, Zhang DZ, Niu XY. Effect of ginsenoside on the cellular proliferation, apoptosis and cell cycles in LC A549 and HUVEC 304 cell lines. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2005;30:149-52 [Chinese].
36 Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.   DOI